A method of treating depression includes locally administering a botulinum toxin subcutaneously to a face of a subject with depression, thereby treating the depression by reducing the occurrence of at least one symptom of depression. The botulinum toxin may be immunotype A or B. The toxin may be administered by injection to the forehead, scalp, face, and/or neck.